9/10
08:01 am
imvt
Immunovant, Inc. (NASDAQ: IMVT) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $51.00 price target on the stock.
Medium
Report
Immunovant, Inc. (NASDAQ: IMVT) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $51.00 price target on the stock.
9/9
05:46 pm
imvt
Immunovant stock falls 8% amid Graves' disease program update Sep. 09, 2024 5:18 PM ET By: Val Brickates Kennedy , SA News Editor [Seeking Alpha]
Medium
Report
Immunovant stock falls 8% amid Graves' disease program update Sep. 09, 2024 5:18 PM ET By: Val Brickates Kennedy , SA News Editor [Seeking Alpha]
9/9
02:14 pm
imvt
Immunovant, Inc. (NASDAQ: IMVT) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald.
Medium
Report
Immunovant, Inc. (NASDAQ: IMVT) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald.
9/9
12:59 pm
imvt
What's Going In With Vivek Ramaswamy-Founded Roivant Sciences Stock On Monday? [Yahoo! Finance]
Medium
Report
What's Going In With Vivek Ramaswamy-Founded Roivant Sciences Stock On Monday? [Yahoo! Finance]
9/9
10:14 am
imvt
IMVT Stock Up on Upbeat Data From Graves' Disease Study of Batoclimab [Yahoo! Finance]
Medium
Report
IMVT Stock Up on Upbeat Data From Graves' Disease Study of Batoclimab [Yahoo! Finance]
9/9
08:32 am
imvt
Immunovant touts positive Phase II batoclimab data as IMVT-1402 also progresses [Yahoo! Finance]
Medium
Report
Immunovant touts positive Phase II batoclimab data as IMVT-1402 also progresses [Yahoo! Finance]
9/9
04:09 am
imvt
Immunovant Provides Update on Graves' Disease Development Program [Yahoo! Finance]
Medium
Report
Immunovant Provides Update on Graves' Disease Development Program [Yahoo! Finance]
9/9
03:55 am
imvt
Immunovant Provides Update on Graves’ Disease Development Program
Medium
Report
Immunovant Provides Update on Graves’ Disease Development Program
9/5
12:54 pm
imvt
Why Is Immunovant (IMVT) Up 13.8% Since Last Earnings Report? [Yahoo! Finance]
Medium
Report
Why Is Immunovant (IMVT) Up 13.8% Since Last Earnings Report? [Yahoo! Finance]
9/5
06:30 am
imvt
Immunovant to Host Graves’ Disease Program Update on September 9, 2024
Medium
Report
Immunovant to Host Graves’ Disease Program Update on September 9, 2024
8/13
11:00 am
imvt
Immunovant, Inc. (NASDAQ: IMVT) had its price target lowered by analysts at UBS Group AG from $42.00 to $41.00. They now have a "buy" rating on the stock.
Low
Report
Immunovant, Inc. (NASDAQ: IMVT) had its price target lowered by analysts at UBS Group AG from $42.00 to $41.00. They now have a "buy" rating on the stock.
8/8
12:22 pm
imvt
Immunovant, Inc. (NASDAQ: IMVT) had its price target lowered by analysts at JPMorgan Chase & Co. from $51.00 to $46.00. They now have an "overweight" rating on the stock.
Low
Report
Immunovant, Inc. (NASDAQ: IMVT) had its price target lowered by analysts at JPMorgan Chase & Co. from $51.00 to $46.00. They now have an "overweight" rating on the stock.
8/7
02:20 pm
imvt
Immunovant, Inc. (NASDAQ: IMVT) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald.
Low
Report
Immunovant, Inc. (NASDAQ: IMVT) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald.
8/6
04:15 pm
imvt
Immunovant Reports Financial Results and Provides Corporate Updates for the Quarter Ended June 30, 2024 [Yahoo! Finance]
Low
Report
Immunovant Reports Financial Results and Provides Corporate Updates for the Quarter Ended June 30, 2024 [Yahoo! Finance]
8/6
04:05 pm
imvt
Immunovant Reports Financial Results and Provides Corporate Updates for the Quarter Ended June 30, 2024
Low
Report
Immunovant Reports Financial Results and Provides Corporate Updates for the Quarter Ended June 30, 2024
7/26
07:14 am
imvt
HanAll Biopharma Reports Q2 2024 Financial Results and Provides Business Update [Yahoo! Finance]
Medium
Report
HanAll Biopharma Reports Q2 2024 Financial Results and Provides Business Update [Yahoo! Finance]
7/23
10:06 am
imvt
We Think Immunovant (NASDAQ:IMVT) Can Afford To Drive Business Growth [Yahoo! Finance]
Low
Report
We Think Immunovant (NASDAQ:IMVT) Can Afford To Drive Business Growth [Yahoo! Finance]
7/8
12:31 pm
imvt
Dianthus (DNTH) Gains 18% in the Past Month: Here's Why [Yahoo! Finance]
Low
Report
Dianthus (DNTH) Gains 18% in the Past Month: Here's Why [Yahoo! Finance]
6/28
01:30 pm
imvt
Immunovant (IMVT) Down 1.6% Since Last Earnings Report: Can It Rebound? [Yahoo! Finance]
Low
Report
Immunovant (IMVT) Down 1.6% Since Last Earnings Report: Can It Rebound? [Yahoo! Finance]